bibliographic entry 1463607 [be/1463607]
https://w3id.org/oc/corpus/be/1463607

is a
content
  • Hassan, R, Bullock, S, Premkumar, A, Kreitman, R.J, Kindler, H, Willingham, M.C, Pastan, I. Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers, Clin. Cancer Res, 2007, 13, 5144, 5149, DOI: 10.1158/1078-0432.CCR-07-0869, PMID: 17785569
references